Skip links

Zulresso® (brexanolone)

Full Name Zulresso® (brexanolone)
Drug Zulresso
Manufacturer Sage Therapeutics
Route of Administration Intravenous
Site of Care Healthcare Facility
Approved Indication The treatment of postpartum depression (PPD) in adults
Disease Postpartum Depression
Therapeutic Area Psychiatry, Mental Health & Addiction
Referral Link Zulresso Enrollment Form
Phone Number 800-811-6109
Fax Number 877-868-9682